| For: | Yang J, Li J, Gu WY, Jin L, Duan YL, Huang S, Zhang M, Wang XS, Liu Y, Zhou CJ, Gao C, Zheng HY, Zhang YH. Central nervous system relapse in a pediatric anaplastic large cell lymphoma patient with CLTC/ALK translocation treated with alectinib: A case report. World J Clin Cases 2020; 8(9): 1685-1692 [PMID: 32420302 DOI: 10.12998/wjcc.v8.i9.1685] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i9/1685.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Milda Mikalonytė, Vilhelmas Landsbergis, Lukas Kevličius, Skirmantė Černauskienė, Linas Davainis, Andrius Žučenka, Igoris Trociukas, Regina Pileckytė, Birutė Davainienė, Inga Šlepikienė, Gintarė Ražanskienė, Ugnius Mickys, Jonas Ražanskas, Jūratė Dementavičienė, Mindaugas Stoškus, Raminta Batiuškaitė, Laimonas Griškevičius. Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1679620
|
| 3 |
Makito Tanaka, Hiroki Miura, Soichiro Ishimaru, Gen Furukawa, Yoshiki Kawamura, Kei Kozawa, Seiji Yamada, Fumitaka Ito, Kazuko Kudo, Tetsushi Yoshikawa. Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse?. Pediatric Reports 2023; 15(2) doi: 10.3390/pediatric15020029
|
| 4 |
Kazuhiro Noguchi, Yasuhiro Ikawa. Strategy for Pediatric Patients with Relapsed or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: A Review. Cancers 2023; 15(24) doi: 10.3390/cancers15245733
|
| 5 |
Eduardo Cambruzzi, Nelson Pires Ferreira, Marcelo Paglioli Ferreira, Guilherme Gago, João Pedro Pattussi Bertinatti. Recurrence of Anaplastic Large Cell Lymphoma in the Frontal Lobe After Eleven Years of the Initial Diagnosis: Histopathological Findings and Prognosis. Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2022; 41(04) doi: 10.1055/s-0042-1749375
|
| 6 |
Ting Zhu, Chun‐Ju Zhou, Lin Jin, Shuang Huang, Meng Zhang, Nan Li, Zhi‐Gang Li, Tian‐You Wang, Jing Yang, Yan‐Long Duan. Clinical Characteristics and Prognostic Analysis of Non‐NPM1‐ALK Fusions in Pediatric Patients With ALK‐Positive Anaplastic Large‐Cell Lymphoma: A Single‐Center Retrospective Study in China. Pediatric Blood & Cancer 2026; 73(2) doi: 10.1002/1545-5017.70045
|
| 7 |
Meng Zhang, Ling Jin, Yan-Long Duan, Jing Yang, Shuang Huang, Mei Jin, Guang-Hua Zhu, Chao Gao, Yi Liu, Nan Zhang, Chun-Ju Zhou, Zi-Fen Gao, Qin-Long Zheng, Dong Chen, Yong-Hong Zhang. Diagnosis and treatment of pediatric anaplastic lymphoma kinase-positive large B-cell lymphoma: A case report. World Journal of Clinical Cases 2021; 9(17): 4268-4278 doi: 10.12998/wjcc.v9.i17.4268
|
| 8 |
Anastasiya S. Volkova. Approaches to therapy of relapsed and refractory forms of anaplastic large cell lymphoma in children and adolescents: A review. Journal of Modern Oncology 2025; 26(4) doi: 10.26442/18151434.2024.4.202906
|
| 9 |
Natalia Georgantzoglou, Donald Green, Kimberly N. Winnick, Janos Sumegi, Gregory W. Charville, Julia A. Bridge, Konstantinos Linos. Molecular investigation of ALK‐rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion‐independent transcription activation. Genes, Chromosomes and Cancer 2022; 61(8) doi: 10.1002/gcc.23038
|